Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

2013/05/09 by Sarah J Tabrizi, Sarah J. Tabrizi, Rachael I. Scahill +20 · 5 citations
Medicine · Neuroscience · #Attention Deficit Hyperactivity Disorder #Genetic Neurodegenerative Diseases #Parkinson's Disease Mechanisms and Treatments

paper · doi:10.1016/s1474-4422(13)70088-7

openalex publication_date 2013/05/09 · crossref created 2013/05/09 · crossref issued 2013/07/01 · crossref published 2013/07/01 · crossref published-print 2013/07/01 · crossref deposited 2024/05/10 · openalex created_date 2025/10/10 · crossref indexed 2026/07/10 · openalex updated_date 2026/07/28

Citations

• The control of the false discovery rate in multiple testing under dependency
• Unified Huntington's disease rating scale: Reliability and consistency

Cited by

• Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
• Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
• Association of CAG Repeats With Long-term Progression in Huntington Disease
• Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis
• Bernhard Landwehrmeyer [wikipedia]